Market Overview
The global Friedreich Ataxia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Friedreich Ataxia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Friedreich Ataxia Drug market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Friedreich Ataxia Drug market has been segmented into ADVM-063, AGIL-FA, BHV-4157, BVA-202, Others, etc.
Breakdown by Application, Friedreich Ataxia Drug has been segmented into Clinic, Hospital, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Friedreich Ataxia Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Friedreich Ataxia Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Friedreich Ataxia Drug market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Friedreich Ataxia Drug Market Share Analysis
Friedreich Ataxia Drug competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Friedreich Ataxia Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Friedreich Ataxia Drug sales, revenue and market share for each player covered in this report.
The major players covered in Friedreich Ataxia Drug are: Adverum Biotechnologies Inc, Pfizer Inc, Cardero Therapeutics Inc, BioMarin Pharmaceutical Inc., Ixchel Pharma LLC, Biovista Inc., RaNA Therapeutics Inc, Forward Pharma A/S, Catabasis Pharmaceuticals, Inc., ProQR Therapeutics NV, Voyager Therapeutics Inc, Reata Pharmaceuticals Inc, STATegics Inc, Retrotope Inc, Takeda, etc. Among other players domestic and global, Friedreich Ataxia Drug market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Friedreich Ataxia Drug market are listed below:
Adverum Biotechnologies Inc
Pfizer Inc
Cardero Therapeutics Inc
BioMarin Pharmaceutical Inc.
Ixchel Pharma LLC
Biovista Inc.
RaNA Therapeutics Inc
Forward Pharma A/S
Catabasis Pharmaceuticals, Inc.
ProQR Therapeutics NV
Voyager Therapeutics Inc
Reata Pharmaceuticals Inc
STATegics Inc
Retrotope Inc
Takeda
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
Market segment by Application, can be divided into
Clinic
Hospital
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Friedreich Ataxia Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Friedreich Ataxia Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ADVM-063
1.2.3 AGIL-FA
1.2.4 BHV-4157
1.2.5 BVA-202
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Friedreich Ataxia Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
1.4.1 Global Friedreich Ataxia Drug Revenue and Forecast (2015-2025)
1.4.2 Global Friedreich Ataxia Drug Sales and Forecast (2015-2025)
1.5 Global Friedreich Ataxia Drug Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Adverum Biotechnologies Inc
2.1.1 Adverum Biotechnologies Inc Details
2.1.2 Adverum Biotechnologies Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Adverum Biotechnologies Inc SWOT Analysis
2.1.4 Adverum Biotechnologies Inc Product and Services
2.1.5 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc SWOT Analysis
2.2.4 Pfizer Inc Product and Services
2.2.5 Pfizer Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cardero Therapeutics Inc
2.3.1 Cardero Therapeutics Inc Details
2.3.2 Cardero Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cardero Therapeutics Inc SWOT Analysis
2.3.4 Cardero Therapeutics Inc Product and Services
2.3.5 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioMarin Pharmaceutical Inc.
2.4.1 BioMarin Pharmaceutical Inc. Details
2.4.2 BioMarin Pharmaceutical Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioMarin Pharmaceutical Inc. SWOT Analysis
2.4.4 BioMarin Pharmaceutical Inc. Product and Services
2.4.5 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ixchel Pharma LLC
2.5.1 Ixchel Pharma LLC Details
2.5.2 Ixchel Pharma LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ixchel Pharma LLC SWOT Analysis
2.5.4 Ixchel Pharma LLC Product and Services
2.5.5 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biovista Inc.
2.6.1 Biovista Inc. Details
2.6.2 Biovista Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biovista Inc. SWOT Analysis
2.6.4 Biovista Inc. Product and Services
2.6.5 Biovista Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 RaNA Therapeutics Inc
2.7.1 RaNA Therapeutics Inc Details
2.7.2 RaNA Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 RaNA Therapeutics Inc SWOT Analysis
2.7.4 RaNA Therapeutics Inc Product and Services
2.7.5 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Forward Pharma A/S
2.8.1 Forward Pharma A/S Details
2.8.2 Forward Pharma A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Forward Pharma A/S SWOT Analysis
2.8.4 Forward Pharma A/S Product and Services
2.8.5 Forward Pharma A/S Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Catabasis Pharmaceuticals, Inc.
2.9.1 Catabasis Pharmaceuticals, Inc. Details
2.9.2 Catabasis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Catabasis Pharmaceuticals, Inc. SWOT Analysis
2.9.4 Catabasis Pharmaceuticals, Inc. Product and Services
2.9.5 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 ProQR Therapeutics NV
2.10.1 ProQR Therapeutics NV Details
2.10.2 ProQR Therapeutics NV Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 ProQR Therapeutics NV SWOT Analysis
2.10.4 ProQR Therapeutics NV Product and Services
2.10.5 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Voyager Therapeutics Inc
2.11.1 Voyager Therapeutics Inc Details
2.11.2 Voyager Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Voyager Therapeutics Inc SWOT Analysis
2.11.4 Voyager Therapeutics Inc Product and Services
2.11.5 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Reata Pharmaceuticals Inc
2.12.1 Reata Pharmaceuticals Inc Details
2.12.2 Reata Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Reata Pharmaceuticals Inc SWOT Analysis
2.12.4 Reata Pharmaceuticals Inc Product and Services
2.12.5 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 STATegics Inc
2.13.1 STATegics Inc Details
2.13.2 STATegics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 STATegics Inc SWOT Analysis
2.13.4 STATegics Inc Product and Services
2.13.5 STATegics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Retrotope Inc
2.14.1 Retrotope Inc Details
2.14.2 Retrotope Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Retrotope Inc SWOT Analysis
2.14.4 Retrotope Inc Product and Services
2.14.5 Retrotope Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Takeda SWOT Analysis
2.15.4 Takeda Product and Services
2.15.5 Takeda Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Friedreich Ataxia Drug Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Friedreich Ataxia Drug Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Friedreich Ataxia Drug Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Friedreich Ataxia Drug Sales in Japan (2018-2019)
3.2.2 Japan Friedreich Ataxia Drug Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Friedreich Ataxia Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Friedreich Ataxia Drug Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Friedreich Ataxia Drug Market Size by Geography (2015-2020)
4.1.1 Global Friedreich Ataxia Drug Sales by Geography (2015-2020)
4.1.2 Global Friedreich Ataxia Drug Revenue by Regions (2015-2020)
4.2 Global Friedreich Ataxia Drug Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Friedreich Ataxia Drug Sales and Forecast by Regions (2020-2025)
4.2.2 Global Friedreich Ataxia Drug Revenue and Forecast by Regions (2020-2025)
4.3 North America Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
4.4 Europe Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
4.6 South America Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Friedreich Ataxia Drug Market Size by Country (2015-2020)
5.1.1 North America Friedreich Ataxia Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Friedreich Ataxia Drug Revenue and Market Share by Country (2015-2020)
5.2 North America Friedreich Ataxia Drug Market Size and Forecast by Country (2020-2025)
5.2.1 North America Friedreich Ataxia Drug Sales and Forecast by Country (2020-2025)
5.2.2 North America Friedreich Ataxia Drug Revenue and Forecast by Country (2020-2025)
5.3 United States Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
5.4 Canada Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
5.5 Mexico Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Friedreich Ataxia Drug Market Size by Country (2015-2020)
6.1.1 Europe Friedreich Ataxia Drug Sales by Country (2015-2020)
6.1.2 Europe Friedreich Ataxia Drug Revenue by Country (2015-2020)
6.2 Europe Friedreich Ataxia Drug Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Friedreich Ataxia Drug Sales and Forecast by Country (2020-2025)
6.2.2 Europe Friedreich Ataxia Drug Revenue and Forecast by Country (2020-2025)
6.3 Germany Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
6.4 United Kingdom Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
6.5 France Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
6.6 Russia Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
6.7 Italy Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Friedreich Ataxia Drug Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Friedreich Ataxia Drug Sales by Region (2015-2020)
7.1.2 Asia-Pacific Friedreich Ataxia Drug Revenue by Region (2015-2020)
7.2 Asia-Pacific Friedreich Ataxia Drug Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Friedreich Ataxia Drug Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Friedreich Ataxia Drug Revenue and Forecast by Region (2020-2025)
7.3 China Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
7.4 Japan Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
7.5 Korea Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
7.6 India Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
7.7 Southeast Asia Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
7.8 Australia Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Friedreich Ataxia Drug Market Size by Country (2015-2020)
8.1.1 South America Friedreich Ataxia Drug Sales by Country (2015-2020)
8.1.2 South America Friedreich Ataxia Drug Revenue by Country (2015-2020)
8.2 South America Friedreich Ataxia Drug Market Size and Forecast by Country (2020-2025)
8.2.1 South America Friedreich Ataxia Drug Sales and Forecast by Country (2020-2025)
8.2.2 South America Friedreich Ataxia Drug Revenue and Forecast by Country (2020-2025)
8.3 Brazil Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
8.4 Argentina Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Friedreich Ataxia Drug Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Friedreich Ataxia Drug Sales by Country (2015-2020)
9.1.2 Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2015-2020)
9.2 Middle East & Africa Friedreich Ataxia Drug Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Friedreich Ataxia Drug Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Friedreich Ataxia Drug Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
9.4 Turkey Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
9.5 Egypt Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
9.6 South Africa Friedreich Ataxia Drug Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Friedreich Ataxia Drug Market Size by Type (2015-2020)
10.1.1 Global Friedreich Ataxia Drug Sales by Type (2015-2020)
10.1.2 Global Friedreich Ataxia Drug Revenue by Type (2015-2020)
10.1.3 Global Friedreich Ataxia Drug Price by Type (2015-2020)
10.2 Global Friedreich Ataxia Drug Market Size and Forecast by Type (2020-2025)
10.2.1 Global Friedreich Ataxia Drug Sales and Forecast by Type (2020-2025)
10.2.2 Global Friedreich Ataxia Drug Revenue and Forecast by Type (2020-2025)
10.2.3 Global Friedreich Ataxia Drug Price and Forecast by Type (2020-2025)
10.3 Japan Friedreich Ataxia Drug Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Friedreich Ataxia Drug Market Size by Type (2015-2020)
10.3.2 Japan Friedreich Ataxia Drug Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Friedreich Ataxia Drug Market Size by Application (2015-2020)
11.1.1 Global Friedreich Ataxia Drug Sales by Application (2015-2020)
11.1.2 Global Friedreich Ataxia Drug Revenue by Application (2015-2020)
11.1.3 Global Friedreich Ataxia Drug Price by Application (2015-2020)
11.2 Global Friedreich Ataxia Drug Market Size and Forecast by Application (2020-2025)
11.2.1 Global Friedreich Ataxia Drug Sales and Forecast by Application (2020-2025)
11.2.2 Global Friedreich Ataxia Drug Revenue and Forecast by Application (2020-2025)
11.2.3 Global Friedreich Ataxia Drug Price and Forecast by Application (2020-2025)
11.3 Japan Friedreich Ataxia Drug Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Friedreich Ataxia Drug Market Size by Application (2015-2020)
11.3.2 Japan Friedreich Ataxia Drug Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Friedreich Ataxia Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Friedreich Ataxia Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Friedreich Ataxia Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Friedreich Ataxia Drug Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Adverum Biotechnologies Inc Basic Information, Manufacturing Base and Competitors
Table 6. Adverum Biotechnologies Inc Friedreich Ataxia Drug Major Business
Table 7. Adverum Biotechnologies Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 8. Adverum Biotechnologies Inc SWOT Analysis
Table 9. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product and Services
Table 10. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Inc Friedreich Ataxia Drug Major Business
Table 13. Pfizer Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer Inc SWOT Analysis
Table 15. Pfizer Inc Friedreich Ataxia Drug Product and Services
Table 16. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Cardero Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 18. Cardero Therapeutics Inc Friedreich Ataxia Drug Major Business
Table 19. Cardero Therapeutics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 20. Cardero Therapeutics Inc SWOT Analysis
Table 21. Cardero Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 22. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. BioMarin Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table 24. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Major Business
Table 25. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 26. BioMarin Pharmaceutical Inc. SWOT Analysis
Table 27. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product and Services
Table 28. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Ixchel Pharma LLC Basic Information, Manufacturing Base and Competitors
Table 30. Ixchel Pharma LLC Friedreich Ataxia Drug Major Business
Table 31. Ixchel Pharma LLC Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 32. Ixchel Pharma LLC SWOT Analysis
Table 33. Ixchel Pharma LLC Friedreich Ataxia Drug Product and Services
Table 34. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Biovista Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Biovista Inc. Friedreich Ataxia Drug Major Business
Table 37. Biovista Inc. Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 38. Biovista Inc. SWOT Analysis
Table 39. Biovista Inc. Friedreich Ataxia Drug Product and Services
Table 40. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. RaNA Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 42. RaNA Therapeutics Inc Friedreich Ataxia Drug Major Business
Table 43. RaNA Therapeutics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 44. RaNA Therapeutics Inc SWOT Analysis
Table 45. RaNA Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 46. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Forward Pharma A/S Basic Information, Manufacturing Base and Competitors
Table 48. Forward Pharma A/S Friedreich Ataxia Drug Major Business
Table 49. Forward Pharma A/S Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 50. Forward Pharma A/S SWOT Analysis
Table 51. Forward Pharma A/S Friedreich Ataxia Drug Product and Services
Table 52. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Catabasis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Major Business
Table 55. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 56. Catabasis Pharmaceuticals, Inc. SWOT Analysis
Table 57. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product and Services
Table 58. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. ProQR Therapeutics NV Basic Information, Manufacturing Base and Competitors
Table 60. ProQR Therapeutics NV Friedreich Ataxia Drug Major Business
Table 61. ProQR Therapeutics NV Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 62. ProQR Therapeutics NV SWOT Analysis
Table 63. ProQR Therapeutics NV Friedreich Ataxia Drug Product and Services
Table 64. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Voyager Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 66. Voyager Therapeutics Inc Friedreich Ataxia Drug Major Business
Table 67. Voyager Therapeutics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 68. Voyager Therapeutics Inc SWOT Analysis
Table 69. Voyager Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 70. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Reata Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 72. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Major Business
Table 73. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 74. Reata Pharmaceuticals Inc SWOT Analysis
Table 75. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product and Services
Table 76. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. STATegics Inc Basic Information, Manufacturing Base and Competitors
Table 78. STATegics Inc Friedreich Ataxia Drug Major Business
Table 79. STATegics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 80. STATegics Inc SWOT Analysis
Table 81. STATegics Inc Friedreich Ataxia Drug Product and Services
Table 82. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Retrotope Inc Basic Information, Manufacturing Base and Competitors
Table 84. Retrotope Inc Friedreich Ataxia Drug Major Business
Table 85. Retrotope Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 86. Retrotope Inc SWOT Analysis
Table 87. Retrotope Inc Friedreich Ataxia Drug Product and Services
Table 88. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. Takeda Basic Information, Manufacturing Base and Competitors
Table 90. Takeda Friedreich Ataxia Drug Major Business
Table 91. Takeda Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 92. Takeda SWOT Analysis
Table 93. Takeda Friedreich Ataxia Drug Product and Services
Table 94. Takeda Friedreich Ataxia Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. Global Friedreich Ataxia Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 96. Global Friedreich Ataxia Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 97. Key Players Friedreich Ataxia Drug Sales in Japan (2018-2019) (K Pcs)
Table 98. Key Players Friedreich Ataxia Drug Sales Market Share in Japan (2018-2019)
Table 99. Key Players Revenue of Friedreich Ataxia Drug in Japan (2018-2019) (USD Million)
Table 100. Global Friedreich Ataxia Drug Sales by Regions (2015-2020) (K Pcs)
Table 101. Global Friedreich Ataxia Drug Sales Market Share by Regions (2015-2020)
Table 102. Global Friedreich Ataxia Drug Revenue by Regions (2015-2020) (USD Million)
Table 103. Global Friedreich Ataxia Drug Sales and Forecast by Regions (2020-2025) (K Pcs)
Table 104. Global Friedreich Ataxia Drug Sales Market Share by Regions (2020-2025)
Table 105. Global Friedreich Ataxia Drug Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 106. Global Friedreich Ataxia Drug Revenue Market Share by Regions (2020-2025) (USD Million)
Table 107. North America Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 108. North America Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 109. North America Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 110. North America Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 111. North America Friedreich Ataxia Drug Sales by Country (2020-2025) (K Pcs)
Table 112. North America Friedreich Ataxia Drug Sales Market Share by Country (2020-2025)
Table 113. North America Friedreich Ataxia Drug Revenue by Country (2020-2025) (USD Million)
Table 114. North America Friedreich Ataxia Drug Revenue Market Share by Country (2020-2025)
Table 115. Europe Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 116. Europe Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 117. Europe Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 118. Europe Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 119. Europe Friedreich Ataxia Drug Sales by Country (2020-2025) (K Pcs)
Table 120. Europe Friedreich Ataxia Drug Sales Market Share by Country (2020-2025)
Table 121. Europe Friedreich Ataxia Drug Revenue by Country (2020-2025) (USD Million)
Table 122. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2020-2025)
Table 123. Asia-Pacific Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 124. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 125. Asia-Pacific Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 126. Asia-Pacific Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 127. Asia-Pacific Friedreich Ataxia Drug Sales by Country (2020-2025) (K Pcs)
Table 128. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Country (2020-2025)
Table 129. Asia-Pacific Friedreich Ataxia Drug Revenue by Country (2020-2025) (USD Million)
Table 130. Asia-Pacific Friedreich Ataxia Drug Revenue Market Share by Country (2020-2025)
Table 131. South America Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 132. South America Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 133. South America Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 134. South America Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 135. South America Friedreich Ataxia Drug Sales by Country (2020-2025) (K Pcs)
Table 136. South America Friedreich Ataxia Drug Sales Market Share by Country (2020-2025)
Table 137. South America Friedreich Ataxia Drug Revenue by Country (2020-2025) (USD Million)
Table 138. South America Friedreich Ataxia Drug Revenue Market Share by Country (2020-2025)
Table 139. Middle East & Africa Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 140. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 141. Middle East & Africa Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 142. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 143. Middle East & Africa Friedreich Ataxia Drug Sales by Country (2020-2025) (K Pcs)
Table 144. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Country (2020-2025)
Table 145. Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2020-2025) (USD Million)
Table 146. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Country (2020-2025)
Table 147. Japan Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 148. Japan Friedreich Ataxia Drug Sales Market Share by Type (2015-2020)
Table 149. Japan Friedreich Ataxia Drug Revenue by Type (2015-2020) (USD Million)
Table 150. Japan Friedreich Ataxia Drug Revenue Market Share by Type (2015-2020)
Table 151. Japan Friedreich Ataxia Drug Sales by Type (2020-2025) (K Pcs)
Table 152. Japan Friedreich Ataxia Drug Sales Market Share by Type (2020-2025)
Table 153. Japan Friedreich Ataxia Drug Revenue by Type (2020-2025) (USD Million)
Table 154. Japan Friedreich Ataxia Drug Revenue Market Share by Type (2020-2025)
Table 155. Global Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 156. Global Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Table 157. Global Friedreich Ataxia Drug Revenue by Application (2015-2020) (USD Million)
Table 158. Global Friedreich Ataxia Drug Revenue Market Share by Application (2015-2020)
Table 159. Global Friedreich Ataxia Drug Price by Application (2015-2020) (USD/Pcs)
Table 160. Global Friedreich Ataxia Drug Sales by Application (2020-2025) (K Pcs)
Table 161. Global Friedreich Ataxia Drug Sales Market Share by Application (2020-2025)
Table 162. Global Friedreich Ataxia Drug Revenue by Application (2020-2025) (USD Million)
Table 163. Global Friedreich Ataxia Drug Revenue Market Share by Application (2020-2025)
Table 164. Global Friedreich Ataxia Drug Price by Application (2020-2025) (USD/Pcs)
Table 165. Japan Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 166. Japan Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Table 167. Japan Friedreich Ataxia Drug Revenue by Application (2015-2020) (USD Million)
Table 168. Japan Friedreich Ataxia Drug Revenue Market Share by Application (2015-2020)
Table 169. Japan Friedreich Ataxia Drug Sales by Application (2020-2025) (K Pcs)
Table 170. Japan Friedreich Ataxia Drug Sales Market Share by Application (2020-2025)
Table 171. Japan Friedreich Ataxia Drug Revenue by Application (2020-2025) (USD Million)
Table 172. Japan Friedreich Ataxia Drug Revenue Market Share by Application (2020-2025)
Table 173. Direct Channel Pros & Cons
Table 174. Indirect Channel Pros & Cons
Table 175. Distributors/Traders/ Dealers List
Table 176. Customers of Friedreich Ataxia Drug
Table 177. Market Opportunities in Next Few Years
Table 178. Market Risks Analysis
Table 179. Market Drivers
List of Figures
Figure 1. Friedreich Ataxia Drug Picture
Figure 2. Global Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. ADVM-063 Picture
Figure 4. AGIL-FA Picture
Figure 5. BHV-4157 Picture
Figure 6. BVA-202 Picture
Figure 7. Others Picture
Figure 8. Friedreich Ataxia Drug Sales Market Share by Application in 2019
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global Friedreich Ataxia Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. Global Friedreich Ataxia Drug Sales Growth Rate (2015-2025) (K Pcs)
Figure 14. Global Friedreich Ataxia Drug Sales Market Share by Manufacturer in 2019
Figure 15. Global Friedreich Ataxia Drug Revenue Market Share by Manufacturer in 2019
Figure 16. Key Players Friedreich Ataxia Drug Revenue Market Share in Japan in 2019
Figure 17. Global Top 5 Friedreich Ataxia Drug Manufacturer Market Share in 2019
Figure 18. Top 3 Friedreich Ataxia Drug Players Market Share in Japan in 2019
Figure 19. Global Friedreich Ataxia Drug Revenue Market Share by Regions in 2019
Figure 20. North America Friedreich Ataxia Drug Sales YoY Growth (2015-2025) (K Pcs)
Figure 21. North America Friedreich Ataxia Drug Revenue YoY Growth (2015-2025) (USD Million)
Figure 22. Europe Friedreich Ataxia Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 23. Europe Friedreich Ataxia Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Asia-Pacific Friedreich Ataxia Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 25. Asia-Pacific Friedreich Ataxia Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. South America Friedreich Ataxia Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 27. South America Friedreich Ataxia Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. Middle East & Africa Friedreich Ataxia Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 29. Middle East & Africa Friedreich Ataxia Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 30. North America Friedreich Ataxia Drug Sales Market Share by Country in 2019
Figure 31. North America Friedreich Ataxia Drug Revenue Market Share by Country in 2019
Figure 32. United States Friedreich Ataxia Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Canada Friedreich Ataxia Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 34. Mexico Friedreich Ataxia Drug Market Size and Growth Rate (2015-2020) (USD Million)
Figure 35. Europe Friedreich Ataxia Drug Revenue Market Share by Country in 2019
Figure 36. Germany Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. United Kingdom Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. France Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Russia Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Italy Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Region 2018
Figure 42. Asia-Pacific Friedreich Ataxia Drug Revenue Market Share by Region 2018
Figure 43. China Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Japan Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Korea Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. India Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Southeast Asia Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Australia Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. South America Friedreich Ataxia Drug Sales Market Share by Country in 2019
Figure 50. South America Friedreich Ataxia Drug Revenue Market Share by Country in 2019
Figure 51. Brazil Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Argentina Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Saudi Arabia Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Turkey Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Egypt Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. South Africa Friedreich Ataxia Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Global Revenue Market Share of Friedreich Ataxia Drug by Type in 2019
Figure 58. Global Revenue Market Share of Friedreich Ataxia Drug by Application in 2019
Figure 59. Sales Channel: Direct Channel vs Indirect Channel